Hypercalcemia is a condition defined by an elevated level of calcium in the blood. It is a common and potentially serious medical condition that can lead to various cardiac complications. Although the clinical significance of hypercalcemia has been recognized for many years, the underlying mechanisms of its cardiac effects remain elusive. This article will explore the hidden cardiac effects of hypercalcemia from an electrocardiogram (ECG) perspective.
Hypercalcemia is a condition characterized by an abnormally high level of calcium in the blood. It is most commonly caused by primary hyperparathyroidism, malignancy, or certain medications. The normal range of calcium in the blood is 8.5 to 10.5 mg/dL. Hypercalcemia is defined as a calcium level greater than 10.5 mg/dL.
The symptoms of hypercalcemia vary depending on the severity of the condition. Mild hypercalcemia may cause no symptoms at all, while more severe cases can lead to a wide range of symptoms, including: • Muscle weakness • Fatigue • Nausea • Vomiting • Confusion • Abdominal pain • Constipation • Increased thirst • Increased urination
Hypercalcemia can have a number of adverse effects on the heart, including arrhythmias, congestive heart failure, and myocardial infarction. The underlying mechanisms of these cardiac effects are not fully understood, but are thought to involve a combination of electrolyte abnormalities, calcium overload, and altered calcium metabolism.
The ECG is a valuable tool for diagnosing and monitoring hypercalcemia. ECG findings in hypercalcemia can include a prolonged QT interval, ST segment depression, T wave inversion, and atrial and ventricular arrhythmias. These findings can be subtle and may not be immediately apparent on a routine ECG.
QT interval prolongation is one of the most common ECG findings in hypercalcemia. The QT interval is the time between the start of the QRS complex and the end of the T wave. It is a measure of the time taken for the ventricles to depolarize and repolarize. Prolongation of the QT interval can lead to the development of torsades de pointes, a potentially life-threatening arrhythmia.
ST segment depression is another common ECG finding in hypercalcemia. ST segment depression is a downward deflection of the ST segment, which is the period between the end of the QRS complex and the beginning of the T wave. It is a marker of myocardial ischemia and can be seen in hypercalcemia due to the increased workload on the heart.
T wave inversion is another common ECG finding in hypercalcemia. T wave inversion is a downward deflection of the T wave, which is the period between the end of the QRS complex and the beginning of the T wave. It is a marker of myocardial ischemia and can be seen in hypercalcemia due to the increased workload on the heart.
Atrial and ventricular arrhythmias are common in hypercalcemia. These arrhythmias can be caused by electrolyte abnormalities, calcium overload, and altered calcium metabolism. Atrial arrhythmias such as atrial fibrillation and atrial flutter can be seen, as well as ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation.
Hypercalcemia is a common and potentially serious medical condition that can lead to a variety of cardiac complications. The underlying mechanisms of these cardiac effects are not fully understood, but are thought to involve a combination of electrolyte abnormalities, calcium overload, and altered calcium metabolism. The ECG is a valuable tool for diagnosing and monitoring hypercalcemia, and can be used to detect subtle changes in the heart such as QT interval prolongation, ST segment depression, and T wave inversion
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Researchers find distinct cell receptors with the potential for new treatments.
3.
It Is Not Just the Royals Who Go Through Cancer.
4.
Researchers Challenge USPSTF's Lung Cancer Screening Criteria
5.
Prostate cancer screening program beneficial in top decile of polygenic risk score
1.
AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology
2.
Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification
3.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
4.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
5.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation